Mark J. Alles, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), bought 7,250 shares at $86.75 ($629K) on 2022-10-31, disclosed to the SEC on 2022-11-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.75 | 3,625 | $314K | 50.0% |
| 2 | $86.75 | 3,625 | $314K | 50.0% |
| Total | $86.75 avg | 7,250 | $629K | 100% |
| Filing → |
| CELG | BUY | 2018-05-17 | $200K | — | Filing → |
| CELG | BUY | 2018-02-08 | $300K | — | Filing → |
| CELG | SELL | 2015-02-10 | $14.1M | — | Filing → |